Both Orai1 and STIM1 knockdown induced sustained proliferation inhibition in glioma C6 cells by using siRNA technology, being the effect of Orai1 silencing more prominent than that of STIM1 silencing [15]. Here, STIM1 is linked to central nervous system cancer.